Abstract:Purpose/Objective(s)To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin.Materials/MethodsPTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system.ResultsThe inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins.ConclusionsThe PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT. Purpose/Objective(s)To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin. To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin. Materials/MethodsPTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system. PTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system. ResultsThe inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins. The inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins. ConclusionsThe PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT. The PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT.

Optimising PTV margins in oesophageal cancer radiotherapy: A modern radiotherapy planning, treatment delivery and verification approach – A single institutional analysis

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Changes in Tumour Volume and Motion During Radiotherapy for Thoracic Oesophageal Cancer.

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Computed Tomography-Based Evaluation of Volume and Position Changes of the Target Region and Organs at Risk During Radiotherapy for Esophageal Cancer: A Pilot Study

EP-1655: Changes of Tumour Volume and Motion in Oesophageal Cancer During Radiotherapy Based on Repeated 4D-CT Scans

Dosimetric Comparison of Different Radial and Longitudinal Margins for Tomotherapy in Esophageal Cancer

Planning Target Volume Margin Definition from Image Guided Hypofractionated Radiation Therapy for Pancreatic Cancer

Study On Optimal Plan Approach For Dual Arcs Volumetric Modulated Arc Therapy For Oropharyngeal Cancer

A Personalized Anisotropic Margin for Cervical Cancer Radiation Therapy Under the Guidance of Daily Iterative Cone-Beam Computed Tomography (iCBCT)

Advantages Of Diagnostic Quality Ct Guided Radiotherapy For Prostate Cancer: Margin Reduction And Dose Escalation

Dosimetric Benefit to Organs at Risk Following Margin Reductions in Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy

Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer

Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy

Planning target volume margin in head and neck cancer patients undergoing radiation therapy: Estimations derived from own data and literature

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer

Detecting the Variations of the Spatial Position and Overlap Ratio for Primary Thoracic Esophageal Cancer Target During Radiation Therapy Based on Repeated 4-Dimensional Ct Scans

Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study

Comprehensive Comparison of Progressive Optimization Algorithm Based Automatic Plan and Manually Planned Treatment Technique for Cervical-Thoracic Esophageal Cancers

Variations of spatial position and overlap ratio for GTV50 and IGTV of primary thoracic esophageal cancer during radiotherapy:a study based on 4DCT scans

OC-0348: Reducing the dosimetric impact of variable gas volume in the abdomen during RT of esophageal cancer